Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors

Retinal diseases were always difficult problem for clinical ophthalmology. Modern methods of their treatment only decrease risk of complications, however in Russia was created better technology for this purpose: peptide bioregulators, which were made by sequential adding of amino acids one to anothe...

Full description

Saved in:
Bibliographic Details
Published inStem cell reviews Vol. 15; no. 3; pp. 439 - 442
Main Authors Khavinson, V., Trofimova, S., Trofimov, A., Solomin, I.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2019
Springer Nature B.V
Subjects
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Cell Biology
Life Sciences
Peptides
Regenerative Medicine/Tissue Engineering
Retina
Stem Cells
Peptide bioregulators
Promoter regions
Short peptides
Retinal diseases
DNA
Binding sites
Online AccessGet full text

Cover

More Information
Summary:Retinal diseases were always difficult problem for clinical ophthalmology. Modern methods of their treatment only decrease risk of complications, however in Russia was created better technology for this purpose: peptide bioregulators, which were made by sequential adding of amino acids one to another, binding with the promoter region of genes, and promoting retinoprotective effect by regulation of their expression, improving the state of the retina.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1550-8943
2629-3269
1558-6804
2629-3277
DOI:10.1007/s12015-019-09882-7